Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.055

Vincenza Conteduca, Cristian Lolli, Ugo De Giorgi

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	European Urology
DOIs	https://doi.org/10.1016/j.eururo.2016.05.028
Publication status	Accepted/In press - 2016

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2016.05.028

Other files and links

Link to publication in Scopus

Cite this

Conteduca, V., Lolli, C., & De Giorgi, U. (Accepted/In press). Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.055. European Urology. https://doi.org/10.1016/j.eururo.2016.05.028

Re : Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.055. / Conteduca, Vincenza ; Lolli, Cristian ; De Giorgi, Ugo.

In: European Urology, 2016.

Research output: Contribution to journal › Article › peer-review

Conteduca, V , Lolli, C & De Giorgi, U 2016, 'Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.055', European Urology. https://doi.org/10.1016/j.eururo.2016.05.028

Conteduca V , Lolli C , De Giorgi U. Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.055. European Urology. 2016. doi: 10.1016/j.eururo.2016.05.028

Conteduca, Vincenza ; Lolli, Cristian ; De Giorgi, Ugo. / Re : Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.055. In: European Urology. 2016.

@article{19fc63092c6b4b5cb621e09b23e684f2,

title = "Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.055",

author = "Vincenza Conteduca and Cristian Lolli and {De Giorgi}, Ugo",

year = "2016",

doi = "10.1016/j.eururo.2016.05.028",

language = "English",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Re

T2 - Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.055

AU - Conteduca, Vincenza

AU - Lolli, Cristian

AU - De Giorgi, Ugo

PY - 2016

Y1 - 2016

UR - http://www.scopus.com/inward/record.url?scp=84975166178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975166178&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2016.05.028

DO - 10.1016/j.eururo.2016.05.028

M3 - Article

AN - SCOPUS:84975166178

JO - European Urology

JF - European Urology

SN - 0302-2838

ER -